This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Drs Dreyer and Lipton¹ review a number of pathophysiological theories and potential therapeutic strategies for treating glaucoma that exploit recent advances in our understanding of glaucoma's cellular pathology. While the possible interventions they describe show great promise, the authors neglect to discuss another approach to the treatment of glaucoma that is of great potential importance—an approach that can achieve reversal of ocular vasospasm as well as improvement of ocular circulation. In the last 30 years many publications have attested that (a) ocular blood flow is compromised by glaucoma; (b) the insult responsible can be vasospastic, and therefore reversible²; and (c) the extent of vasospasm can be correlated with degree of visual defect.³ It is irrelevant whether ischemia is the primary insult or a result of increased pressure, since improvement of circulation by treatment with vasodilators such as calcium channel blockers has been shown to benefit glaucoma . . . [Full Text of this Article]